1. Kessler R., Faller M., Fourgaut G. et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159 (1): 158–164.

2. Авдеев С.Н. Легочная гипертензия при хронических респираторных заболеваниях. В кн.: Чучалин А.Г. (ред.). Пульмонология. Национальное руководство. М.: ГЭОТАР-Медиа; 2009. 599–619.

3. Авдеев С.Н. Вторичная легочная гипертензия. В кн.: Беленкова Ю.Н., Оганова З.Г. (ред.). Кардиология: Национальное руководство. Краткое издание. М.: ГЭОТАР-Медиа; 2012. 761–766.

4. Weitzenblum E., Hirth C., Ducolone A. et al. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 1981; 36: 752–758.

5. Bishop J.E. Hypoxia and pulmonary hypertension in chronic bronchitis. Prog. Respir. Res.1975; 9: 10–16.

6. Semmens M., Reid L. Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br. J. Dis. Chest 1974; 68: 253–263.

7. MacNee W. State of the art: Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (Part 1). Am. J. Respir. Crit. Care Med. 1994; 150: 833–852.

8. MacNee W. State of the art: Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease (Part 2). Am. J. Respir. Crit. Care Med. 1994; 150: 1158–1168.

9. Попова К.А., Авдеев С.Н. Значение натрийуретических пептидов в диагностике сердечной недостаточности и других заболеваний. Пульмонология 2006; 4: 106–111.

10. Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (3-й пересмотр). Сердеч. недостаточность 2010; 11 [1 (57)]: 3–62.

11. Global Strategy for Diagnosis, Management, and Prevention of COPD (updated 2010). www.goldcopd.org

12. Galie N., Torbicki A., Barst R. et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur. Heart J. 2004; 25: 2243–2278.

13. Quanjer Ph.H., Tammeling G., Cotes J.E. et al. Lung volumes and forced ventilatory flows. Eur. Respir. J. 1993; 6 (Suppl. 16): 5–40.

14. Berger M., Haimovitz A., Van Tosh A. et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J. Am. Coll. Cardiol. 1985; 6: 359–365.

15. Kircher B., Himelman R.B., Schiller M.B. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am. J. Cardiol. 1990; 66 (4): 493–496.

16. Chaouat A., Begnet A.S., Kadaoui N. et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2005; 172: 189–194.

17. Scharf S.M., Iqbal M., Keller C. et al. Hemodynamic characterization of patients with severe emphysema. Am. J. Respir. Crit. Care Med. 2002; 166: 314–322.

18. Vizza C.D., Lynch J.P., Ochoa L.L. et al. Right and left ventricular dysfunction in patients with severe pulmonary disease. Chest 1998; 113: 576–583.

19. Thabut G., Dauriat G., Stern J.B. et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127: 1531–1536.

20. Yap L.B., Mukerjee D., Timms P.M. et al. Natriuretic peptides, respiratory disease, and the right heart. Chest 2004; 126: 1330–1336.

21. Mueller C., Scholer A., Laule,Kilian K. et al. The use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med. 2004; 350: 647–654.

22. Cargill R.I., Lipworth B.J. Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans. Br. J. Clin. Pharmacol. 1995; 40: 585–590.

23. de Lemos J.A., McGuire D.K., Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 2003; 362: 316–322.

24. Klinger J.R., Houtchens J.E., Thaker S. et al. Acute cardiopulmonary hemodynamic effects of brain natriuretic peptidein patients with pulmonary arterial hypertension. Chest 2005; 128 (6, Suppl.): 618S–619S.

25. Lang C.C., Coutie W.J., Struthers A.D. et al. Elevated levels of brain natriuretic peptide in acute hypoxaemic chronic pulmonary disease. Clin. Sci. (Lond.) 1992; 83: 529–533.

26. Fujii T., Otsuka T., Tanaca S. et al. Plasma endothelin-1 level in chronic obstructive pulmonary disease: relationship with natriuretic peptide. Respiration 1999; 66: 212–219.

27. Cabanes L., Richand,Thiriez B., Fulla Y. et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 2001; 120: 2047–2050.

28. Morrison L.K., Harrison A., Krishmaswamy P.I. et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnoea. J. Am. Coll. Cardiol. 2002; 39: 202–205.

29. Tulevski I., Groenink M., Evan der Well E. et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27–30.

30. Gerbes A.L, Dagnino L., Nguyen T., Nemer M. Transcription of brain natriuretic peptide genes in human tissues. J. Clin. Endocrinol. Metab. 1994; 78: 1307–1311.

31. Maisel A.S., Krishnaswamy P., Nowak R.M. et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002; 347: 161–167.

32. Bando M., Ishii Y., Sugiyama Y. et al. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonary. Respir. Med. 1999; 93: 507–514.

33. Bozkanat E., Tozkoparan E., Baysan O. et al. The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease. J. Int. Med. Res. 2005; 33 (5): 537–544.

34. Stolz D., Breidthardt T., Christ,Crain M. et al. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD. Chest 2008; 133 (5): 1088–1094.

35. Tanaka T., Kanda T., Takahashi T. et al. Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. J. Int. Med. Res. 2004; 32 (1): 57–61.